Risk Factors for Nodal Metastasis in cN0 Papillary Thyroid Microcarcinoma |
Zhang, Li-Yang
(General Surgery Department, Peking Union Medical College Hospital, Chinese Academy of Medical Science)
Liu, Zi-Wen (General Surgery Department, Peking Union Medical College Hospital, Chinese Academy of Medical Science) Liu, Yue-Wu (General Surgery Department, Peking Union Medical College Hospital, Chinese Academy of Medical Science) Gao, Wei-Sheng (General Surgery Department, Peking Union Medical College Hospital, Chinese Academy of Medical Science) Zheng, Chao-Ji (General Surgery Department, Peking Union Medical College Hospital, Chinese Academy of Medical Science) |
1 | Adolfo Pisanu, Alessandra Saba, Mauro Podda, et al (2014). Nodal metastasis and recurrence in papillary thyroid microcarcinoma. Endocrine, [Epub ahead of print]. |
2 | Choi YJ, Yun JS, Kook SH, et al (2010). Clinical and imaging assessment of cervical lymph node metastasis in papillary thyroid carcinomas. World J Surg, 34, 1494-9. DOI |
3 | Connor MP, Wells D, Schmalbach CE (2011). Variables predictive of bilateral occult papillary microcarcinoma following total thyroidectomy. Otolaryngol Head Neck Surg, 144, 210-5. DOI |
4 | DeLellis RA, Lloyd RV, Heitz PU, et al (2004). Pathology and genetics of tumors of endocrine organs, in World Health Organization classification of tumors. (IARC Press, Lyon):64-6. |
5 | Dunki-Jacobs E, Grannan K, McDonough S, et al(2012). Clinically unsuspected papillary microcarcinomas of the thyroid: a common finding with favorable biology? Am J Surg, 203, 140-4. DOI |
6 | Hughes DT, White ML, Miller BS, et al (2010). Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery, 148, 1100-6. DOI |
7 | Hay ID, Hutchinason M E, Gonzalez-Losada T, et al(2008). Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery, 144, 980-7. DOI |
8 | He Q, Zhuang D, Zheng L, et al (2012). The surgical management of papillary thyroid microcarcinoma: a 162-month singlecenter experience of 273 cases. Am Surg, 78, 1215-8. |
9 | Jovanovic L, Delahunt B, McIver B, et al (2010). Distinct genetic changes characterise multifocality and diverse histological subtypes in papillary thyroid carcinoma. Pathology.42:524-33. DOI |
10 | Kim, K.-E., Kim, E.-K., Yoon, J.H. et al (2013). Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features. World J Surg, 37, 385-9. DOI |
11 | Lin KD, Lin JD, Huang MJ, et al (1997). Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int Surg, 82, 378-81. |
12 | Lundgren CI, Hall P, Dickman PW, Zedenius J (2006). Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer, 106, 524-31. DOI |
13 | Mercante G, Frasoldati A, Pedroni C, et al (2009). Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid, 19, 707-16. DOI |
14 | Park JP, Roh JL, Lee JH, et al (2014). Risk factors for central neck lymph node metastasis of clinically noninvasive, node-negative papillary thyroid microcarcinoma. Am J Surg, 208, 412-8. DOI |
15 | Mazzaferri EL, Doherty GM, Steward DL (2009). The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid, 19, 683-9. DOI |
16 | Mazeh H, Samet Y, Hochstein D, et al (2011). Multifocality in well differentiated thyroid carcinomas calls for total thyroidectomy. Am J Surg, 201, 770-5. DOI |
17 | Palazzo FF, Gosnell J, Savio R, et al (2006). Lymphadenectomy for papillary thyroid cancer: changes in parctice over four decades[J]. European J Surg Oncol, 32, 340-4. DOI |
18 | Roti E, Rossi R, Trasforini G, et al (2006). Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab, 91, 2171-8. DOI |
19 | Vergez S, Sarini J, Percodani J, et al (2010). Lymph node management in clinically node-negative patients with papillary thyroid carcinoma. Eur J SurgOncol, 36, 777-82. |
20 | White ML, Gauger PG, Doherty GM (2007). Central lymph nodedissection in differentiated thyroid cancer. World J Surg, 31, 895-904. DOI |
21 | Yang Y, Chen C, Chen Z, et al (2014). Prediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma. Clin Endocrinol, 81, 282-8. DOI |
22 | Zhao Q, Ming J, Liu C, et al (2013). Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann Surg Oncol, 20, 746-52. DOI |